Decreasing Vancomycin Utilization in the NICU by Optimizing Treatment Decisions in Suspected Late Onset Sepsis

BACKGROUND: Late Onset Sepsis (LOS) is frequently suspected in NICU patients in the setting of nonspecific clinical symptoms. Based on institutional antibiogram data, empiric treatment of LOS in our NICU is vancomycin and amikacin with a plan to deescalate or discontinue based on culture results and...

Descripción completa

Detalles Bibliográficos
Autores principales: Maffei, Diana, Aggarwal, Alpna, Riccobono, Denise, Rubin, Lorry, Gennattasio, Annmarie, Tarulli, Brianna, Ranieri, Linda, Gee, Karen, Weinberger, Barry
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5630785/
http://dx.doi.org/10.1093/ofid/ofx163.1306

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5630785/
http://dx.doi.org/10.1093/ofid/ofx163.1306

Ejemplares similares